Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | integrin alpha 3 | 0.1308 | 0.2886 | 0.3444 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.0375 | 0.0375 |
Schistosoma mansoni | integrin alpha-ps | 0.0765 | 0.139 | 0.185 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0668 | 0.1123 | 0.1191 |
Echinococcus granulosus | integrin alpha ps | 0.0367 | 0.0293 | 0.0129 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0378 | 0.0324 | 0.5 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0378 | 0.0324 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1291 | 0.2838 | 0.2838 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0378 | 0.0324 | 0.5 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0378 | 0.0324 | 0.5 |
Echinococcus multilocularis | integrin alpha ps | 0.0765 | 0.139 | 0.1532 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.1706 | 0.3983 | 0.3864 |
Brugia malayi | hypothetical protein | 0.065 | 0.1074 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0398 | 0.038 | 0.038 |
Brugia malayi | Telomerase reverse transcriptase | 0.1006 | 0.2054 | 0.1898 |
Loa Loa (eye worm) | hypothetical protein | 0.134 | 0.2973 | 0.2973 |
Loa Loa (eye worm) | hypothetical protein | 0.0941 | 0.1876 | 0.1876 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.1291 | 0.2838 | 0.2697 |
Echinococcus granulosus | integrin alpha ps | 0.0765 | 0.139 | 0.1532 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0396 | 0.0375 | 0.0185 |
Echinococcus granulosus | integrin beta 2 | 0.3169 | 0.8013 | 1 |
Onchocerca volvulus | Telomerase reverse transcriptase homolog | 0.1384 | 0.3095 | 0.5 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.263 | 0.6528 | 0.6528 |
Schistosoma mansoni | integrin alpha | 0.1706 | 0.3983 | 0.6223 |
Loa Loa (eye worm) | integrin beta-2 | 0.3891 | 1 | 1 |
Echinococcus multilocularis | integrin alpha ps | 0.0367 | 0.0293 | 0.0129 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0378 | 0.0324 | 0.5 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0378 | 0.0324 | 0.5 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.065 | 0.1074 | 0.1074 |
Loa Loa (eye worm) | hypothetical protein | 0.0367 | 0.0293 | 0.0293 |
Echinococcus multilocularis | integrin beta 2 | 0.3169 | 0.8013 | 1 |
Brugia malayi | Kelch motif family protein | 0.065 | 0.1074 | 0.0898 |
Schistosoma mansoni | integrin alpha-ps | 0.0398 | 0.038 | 0.0147 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0668 | 0.1123 | 0.1191 |
Schistosoma mansoni | integrin beta subunit | 0.2519 | 0.6223 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.0378 | 0.0324 | 0.5 |
Echinococcus granulosus | integrin alpha 3 | 0.1308 | 0.2886 | 0.3444 |
Loa Loa (eye worm) | hypothetical protein | 0.065 | 0.1074 | 0.1074 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0378 | 0.0324 | 0.5 |
Echinococcus multilocularis | integrin alpha ps | 0.0765 | 0.139 | 0.1532 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 2.2 nM | Binding affinity against Opioid receptor kappa 1 of guinea pig brain membranes using 1 nM of (-)-[3H]-ethylketazocine as radioligand | ChEMBL. | 2879914 |
Ki (binding) | = 2.3 nM | Binding affinity against Opioid receptor mu 1 of guinea pig brain membranes using 0.5 nM of [3H]-naloxone as radioligand | ChEMBL. | 2879914 |
Ki (binding) | = 5.7 nM | Binding affinity against Opioid receptor delta 1 of guinea pig brain membranes using 1 nM of [3H]-DADLE as radioligand | ChEMBL. | 2879914 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.